Literature DB >> 15104376

Omental mass secondary to metastatic breast cancer.

Ehab Elakkary1, Amit Dwivedi, Shivana Prakash.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15104376     DOI: 10.1023/b:ddas.0000017457.11287.23

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Natural history of untreated breast cancer (1805-1933). Comparison of untreated and treated cases according to histological grade of malignancy.

Authors:  H J BLOOM; W W RICHARDSON; E J HARRIES
Journal:  Br Med J       Date:  1962-07-28

2.  Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.

Authors:  D F Hayes; V R Zurawski; D W Kufe
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

3.  Patterns of occurrence of second primary non-mammary malignancies in breast cancer patients: results from 1382 consecutive autopsies.

Authors:  E P Mamounas; C Perez-Mesa; R B Penetrante; D L Driscoll; L E Blumenson; T N Tsangaris
Journal:  Surg Oncol       Date:  1993       Impact factor: 3.279

4.  Clinical correlation between CEA and breast cancer.

Authors:  D C Tormey; T P Waalkes
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

5.  Mesenchymal solid tumors of the omentum and mesentery: report of four cases.

Authors:  H A Weinberger; M S Ahmed
Journal:  Surgery       Date:  1977-11       Impact factor: 3.982

6.  Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

Authors:  C Tondini; D F Hayes; R Gelman; I C Henderson; D W Kufe
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

7.  Percutaneous image-guided fine-needle aspiration of peritoneal lesions.

Authors:  Lester J Layfield; Evelyn V Gopez
Journal:  Diagn Cytopathol       Date:  2003-01       Impact factor: 1.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.